We aim to:
• Expand the phenotypic spectrum of LYRM7 deficiency,
• Identify new mutations and clinical presentations,
• Assess long-term outcomes with mitochondrial therapy.
Currently, we welcome collaborations for clinical data sharing, molecular diagnostics, and natural history studies. Please contact us at hind.alsharhan@ku.edu.kw for collaboration.